7/28/16
Due to the Meningitis outbreak among MSM in Southern California, recommendations for Meningococcal vaccine has been expanded to include all MSM in addition to all persons with HIV infection. The recommended vaccine is MCV4 the quadrivalent vaccine that covers N. meningitidisserogroups A, C, Y & W-135, trade names Menactra® manufactured by Sanofi Pasteur and Menveo® manufactured by Novartis. Important details may be found in the alert here Los Angeles County Health Alert Network.